Today: 21 May 2026
Browse Category

UK Stocks 6 November 2025 - 25 November 2025

UK Stock Market Today, 24 November 2025: FTSE 100 Edges Higher on Fed Cut Hopes, Budget Jitters and Ukraine Peace Optimism

UK Stock Market Today, 24 November 2025: FTSE 100 Edges Higher on Fed Cut Hopes, Budget Jitters and Ukraine Peace Optimism

The FTSE 100 edged up 0.1% to around 9,549 on Monday, with banks and housebuilders leading gains while defence stocks lagged. The FTSE 250 rose 0.3% to about 21,432, ending an eight-day losing streak. Sterling traded near $1.31. Investors weighed hopes for a US Fed rate cut, Wednesday’s UK budget, and signs of progress toward a Ukraine peace deal.
24 November 2025
·
RELX PLC Share Price: What to Know Before the London Market Opens on 17 November 2025

RELX PLC Share Price Today (LON: REL): UK Stock Climbs Against a Falling FTSE 100 – 21 November 2025

RELX shares closed up 1.9% at 3,086p in London on Friday, bucking a broad FTSE 100 decline of about 0.6%. The stock outperformed as investors favored defensive names amid renewed concerns over an AI-driven market bubble. RELX’s market cap stood near £56.1bn, with volume just over 1.1 million shares. No new company statements were issued Friday.
21 November 2025
··
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

UK Stocks Today (13 Nov 2025): FTSE 100 slips as 3i plunges, Aviva underwhelms; weak Q3 GDP and softer oil weigh on London

The FTSE 100 dropped about 1% Thursday, ending its streak of record closes as financial and energy shares fell. UK GDP grew just 0.1% in Q3, missing forecasts and boosting bets on a December Bank of England rate cut. 3i Group plunged over 14%, while Burberry and Wizz Air shares rallied on strong results. Sterling edged up 0.2% against the dollar.
13 November 2025
·······
Caledonian Holdings (CHP.L) pops on 11 November: price crosses key averages; no new RNS as AlbaCo deal continues to set the tone

Caledonian Holdings (CHP.L) pops on 11 November: price crosses key averages; no new RNS as AlbaCo deal continues to set the tone

Caledonian Holdings shares jumped 33% to 0.004p in London by 14:50 GMT, with no new regulatory filings. Traders cited momentum from recent AlbaCo share-swap news and last week’s admission of 12.5 billion new shares. The move coincided with a rally in UK stocks after jobs data fueled rate-cut hopes. Total CHP voting rights now stand at 115.8 billion.
11 November 2025
··
Haleon (HLN.L) Share Price Today: UK Stock Climbs as Vindi Banga Named Chair — 11 November 2025

Haleon (HLN.L) Share Price Today: UK Stock Climbs as Vindi Banga Named Chair — 11 November 2025

Haleon shares closed up 2.64% at 372.7p in London Tuesday after coverage of its leadership change, with Vindi Banga set to replace Sir Dave Lewis as chair on 1 January 2026. The move follows Lewis’s planned departure to become Diageo CEO. Haleon’s US ADR traded near $9.57, up about 1.2% intraday. AssetMark Inc. reduced its stake in Haleon’s ADR during Q2, according to a recent 13F filing.
11 November 2025
···
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

FTSE 100 Jumps on US Shutdown Hopes as Diageo Soars; BoE Stablecoin Plan and Gold Rally Lift London Stocks — UK Market Wrap (10 November 2025)

FTSE 100 rose about 1% to near 9,780 by late morning, lifted by Diageo’s 7–8% surge after naming Sir Dave Lewis as CEO and a rally in gold miners as spot gold hit $4,070/oz. Gains tracked a European rebound after US Senate steps to end the government shutdown. UK 10-year gilt yields edged up to 4.49%. Sterling held steady at $1.3175.
10 November 2025
····
London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

UK stocks today (6 Nov 2025): FTSE 100 edges lower before BoE decision; Sainsbury lifts profit guidance, ITV warns on Q4 ads, AstraZeneca beats

The UK FTSE 100 edged down as investors awaited the Bank of England’s rate decision, with sterling near multi-month lows. October construction PMI fell to 44.1, the steepest drop in over five years. Sainsbury raised profit guidance and announced a special dividend. ITV warned of a 9% Q4 ad revenue decline and £35m in temporary savings.
6 November 2025
········
1 2 3

Stock Market Today

  • Stock Market Today: Key Insights for May 21 Trading
    May 20, 2026, 10:27 PM EDT. Stocks in the news and major brokerage calls shape market sentiment as traders prepare for May 21. This report provides a complete trade setup, highlighting critical market movements and strategies. Stay informed with the essential data before entering trades today.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop